Industry symposia
The IDF World Diabetes Congress 2025 features 130 hours of scientific sessions, with more than 250 international speakers including some of the top experts in diabetes today.
Industry symposia are an integral part of the congress programme, offering high-quality content and high-level speakers.
Companies operating in the field of diabetes value IDF Congresses as relevant and impactful opportunities to present the latest research and share innovative products with an international audience of health professionals.
Browse the full industry symposia programme below.
All times ICT (UTC+7).
Monday, 7 April
10:00-11:45
Silk 1
Diabetes India Satellite Symposium
Programme
Chairs: Dr Ashok Kumar Das, Dr Abhay Sahoo
Type 2 Diabetes in India: State of the Nation
Dr. A K Das
Unholy Trinity of Sugar, Salt, and Butter in Metabolic Syndrome
Dr. Hemant P Thacker
FDCs - Made in India: Paving The Path Towards Improved Global Glycemic Care
Dr. Purvi Chawla
Programme
Comprehensive Management of Type 2 Diabetes Using Blue Index, a Motivational Diabetes Scores
Dr. Sanjeev Pathak
Evolution of Glycemic Monitoring and What the Future Promises us
Dr. Jayant Panda
Future of Telemedicine & Remote Diabetes Management
Dr. Bharat Saboo
Revolutionising AI-powered screening for Diabetic Retinopathy, AMD and Glaucoma
Dr. Bhavana Sosale
Monday, 7 April
12:00-14:00
Nile 1
Abbott Libre Academy: Revolutionizing Diabetes Care | CGM Essentials to Unlocking Progress
Programme
Chair: Deerochanawong, Chaicharn
Beyond HbA1c: Enhancing Diabetes Care with CGM
Enhancing Clinical Outcomes with CGM: Evidence and Insights
Overview of CGM Guidelines and Consensus
The Essentials of Glucose Monitoring: FreeStyle Libre
Integrating FreeStyle Libre into Clinical Workflow: Reports and Interpretation
Programme
Question and Answers and Closing Remarks
Speakers: Hussain, Syed Sufyan (United Kingdom) & Mader, Julia (Austria)
Monday, 7 April
12:15-14:00
Silk 1
DASG Satellite Symposium
Programme
Chairpersons: Dr. Juliana Chan (Hong Kong), Dr. Asher Fawwad (Pakistan)
Subtyping Diabetes in Asians
Dr. Daphne Gardner (Singapore) Heterogeneity of Young Onset Diabetes
Dr. Juliana Chan (Hong Kong) Is there a Gender Difference of Heart & Kidney Complications in People with Diabetes?
Dr. Lee Ling Lim (Malaysia)
Dr. Daphne Gardner (Singapore) Heterogeneity of Young Onset Diabetes
Dr. Juliana Chan (Hong Kong) Is there a Gender Difference of Heart & Kidney Complications in People with Diabetes?
Dr. Lee Ling Lim (Malaysia)
Programme
Inflammation in Pathogenesis of Diabetes and it’s Complications
Dr. Daphne Gardner (Singapore)
A Framework to Combat Growing Epidemic of Young-Onset Type 2 Diabetes in Asia
Dr. Rakesh Parikh (India)
Panel Discussion: Challenges and Innovations in Diabetes Management
Moderated by: Dr. Asher Fawwad (Pakistan)
Monday, 7 April
14:30-16:30
Silk 1
Diabetes in Asia: Understanding Risk, Environment, and Innovative Management Strategies in China and Beyond
Programme
Disease burden of obesity and related chronic diseases in China and intervention efforts Youfa
Wang
Trends in prevalence of diabetes, related management, and risk factors in China Limin Wang
Regional and ethnic disparities in obesity and related non-communicable diseases in China Wen
Peng
Diabetes Self-management in the Digital Age: Digital and Intelligent Diabetes Shared-care Management Beijing Model Junqing
Zhang
Programme
Practices of prevention and treatment of diabetes in China Juhong Yang
Diabetes prevention and treatment in East Asia- emerging trends and future directions Ronald
Ma
Tuesday, 8 April
12:30-13:30
Amber
Shape the future of Nerve Health - Empower the patient
Programme
Welcome and introduction
Diabetic Neuropathy: Can we do better?
Prof Rayaz Malik (Qatar)
The new ACT tool – empowering the patient to act
Dr. Hoda Gad (Qatar)
Validation of the ACT Tool in Latin America: Ecuador Pilot
Dr. C. Solis. Sanchez (Ecuador)
Solving the puzzle of diabetic peripheral neuropathy
Panel discussion, international expert panel
Tuesday, 8 April
12:30-13:30
Grand Hall 201
Implementing MNT in diabetes management: Time to move the needle
Programme
Chair: Dr. Jose Rodolfo Dimaano Jr
12h30 – 13h10: Panel discussion
Welcome and introduction
Moderator led Q&A discussion with the panel of experts
Expert Panellists:
Prof V Mohan (India)
Prof Winnie Chee (Malaysia)
Prof Chaicharn Deerochanawong (Thailand)
Programme
13h10-13h25: Translating the latest evidence of MNT in diabetes management
Prof Siew Ling Tey (Singapore)
13h25-13h30: Concluding
Summary of the session proceedings and discussion
Moderator: Dr. Jose Rodolfo Dimaano Jr (the Philippines)
Tuesday, 8 April
12:30-13:30
Grand Hall 202
Optimizing Care in Heart Failure, Chronic Kidney Disease and Diabetes with non-steroidal MRAs
Programme
Chairs: Linong Ji (China), Alice Cheng (Canada)
Welcome and introduction
Kidney disease in Type 1 and Type 2 Diabetes: Bridging the gaps Per-Henrik Groop (Finland)
New paths to improve outcomes in heart failure John McMurray (UK)
Programme
Non-steroidal MRAs in cardiovascular, kidney, and diabetes care: practical considerations Luc van Gaal (Belgium)
Discussion & Closure
Alice Cheng (Canada)
Organized by Sciarc, kindly supported by Bayer AG.
Tuesday, 8 April
12:30-13:30
Nile 1
New insights into treatment of Type 2 diabetes
Programme
Chair: Lynch, Amber
Is progression of β-cell dysfunction in Type 2 diabetes inevitable?
Hussain, Sufyan GIP and GLP-1 receptor agonist mechanism of action in Type 2 diabetes
Rachman, Jonathan Panel Question and Answer
Hussain, Sufyan GIP and GLP-1 receptor agonist mechanism of action in Type 2 diabetes
Rachman, Jonathan Panel Question and Answer
Programme
Panel discussion
WHO PQ or Regional Offices, Life for A Child, Action for Diabetes,
EVA Pharma, Egypt MOH.)
Question & Answer
Tuesday, 8 April
12:30-13:30
Nile 2
The Beauty and Opportunity of Breath Ketone to Transform Diabetes Care
Programme
Welcoming remarks and brief introduction
Dr Christine Yip, CEO & Founder of AusMed Global (China)
Ketone measurements in diabetes management
Prof Lee Chi Ho Paul (Hong Kong)
The Synergy of digital twin technology and breath ketone measurement for diabetes care
Prof Joe Dong (Hong Kong)
Programme
Efficacy and safety of GLP1Ra combination therapy: a population-based cohort study
Prof Gary Tse (Hong Kong)
Question & Answers
Dr Christine Yip and faculty
Tuesday, 8 April
17:30-19:30
Nile 2
Global Health session “How Private Sector Can Help Improve Access to Health Care: A Case of Lilly”
Programme
Access to healthcare landscape – supply- and demand-side barriers to access
Strategic collaborations to advance access to health care – LFAC/DR Cold Chain, A4D
Access expansion to insulins – collaboration with EVA Pharma
VLA as an access expansion tool
Programme
Panel discussion
WHO PQ or Regional Offices, Life for A Child, Action for Diabetes,
EVA Pharma, Egypt MOH.)
Question & Answer
Tuesday, 8 April
12:30-13:30
Silk 1
Assessing and addressing needs in T2D for glycemic control, cardiorenal protection and adherence: What are our options?
Programme
Chair: Kamlesh Khunti (UK)
Introduction
Glycaemic control and Cardiorenal benefits: Together or one over the other?
Ashwani Mehta (India), Juliana Chan (Hong Kong)
The paramount importance of Glycaemic control: What are our options?
Mohamed M Hassanein (UAE)
Programme
Simplifying adherence for people with type 2 diabetes: What are the unmet needs ?
Somia Iqtadar (Pakistan), Narsimha Raju Dichpally (India)
Discussion
Tuesday, 8 April
17:30-19:30
Silk 2
From Namaste to Sawasdee: A night of continuous connection
Programme
Chair: Lee, Kenneth (Singapore)
From Data to Decisions:
Leveraging CGM for Clinical Excellence
Prof. Satish Garg (USA)
From BGM to CGM:
Enhancing Diabetes Care In India with Cost-Effective Monitoring
Mohan, Viswanathan (India)
Speed Networking:
Ignite Continuous Connections
All faculty
Tuesday, 8 April
12:30-13:30
Meeting Room 216
Bridging gaps: Integrated strategies to address TB and Diabetes
Programme
Overview of burden and latest WHO guidance to address TB and Diabetes
Baddeley, Annabel (Switzerland)
Impact and feasibility of integrated TB and Diabetes care - synthesis of the evidence and
research gaps
Nyirenda, John L.Z. (Germany)
Panel discussion - Scaling up collaborative action on TB and diabetes -
challenges, opportunities, and what will it take?
People with lived experience of TB and diabetes
Tuesday, 8 April
17:30-19:30
Nile 1
The time is now: improving access to diabetes care in a strengthened global policy framework
Programme
Introductory remarks
IDF President-elect and Dr Anil Kapur, WDF Board Chairman
Keynote intervention
Dr Guy Fones, Director a.i, WHO Noncommunicable Diseases,
Rehabilitation and Disability (NCD)
Keynote intervention
Ms Anita Sabidi, Blue Circle Voices member
Programme
Panel 1 – Implementing diabetes programmes as part of the national NCD strategy
Dr Nilufar Ibragimova, Dr Silvia Lapertosa, Ms Rachel Nungu, and Ms Nurianne Arias
Panel 2 – The Global Diabetes Compact as a unifying dynamic
Prof Abdul Basit, Ms Lucia Feito Allonca, Ms Osarenkhoe Ethel Chima-Nwogwugwu, Prof Alicia Jenkins
Reflections and plenary debate
Dr Guy Fones, Dr Jackie Maalouf, and Dr Anil Kapur
Wednesday, 9 April
12:30-13:30
Amber
Holistic and connected diabetes management: Insights from the patient’s perspective
Programme
Chair: Abdul Basit (Pakistan)
The transformative impact of emotional support and education of digital diabetes technology - Juliana Chan (Hong Kong)
Empowering patients through blood glucose monitoring: Fostering ownership and enhancing lifestyle behaviors - Jothydev Kesavadev (India).
Collaboration in action: Bridging healthcare support and patient-driven decisions in diabetes management - Nitchakarn Laichuthai (Thailand)
Wednesday, 9 April
12:30-13:30
Diabetes spotlight
Breaking Barriers in Peripheral Neuropathy Management– From Silent Suffering to Superior Treatment
Programme
Chair: Dr. LI Yan (Singapore)
One-stop-shop diagnosis of Diabetic Complications and Diabetic Peripheral Neuropathy
Dr. Dela Pena Pepito (the Philippines) Role of High-Dose Neurotropic B vitamins in the management of Peripheral Neuropathy
Dr. Pinzon Rizaldy Taslim (Indonesia)
Dr. Dela Pena Pepito (the Philippines) Role of High-Dose Neurotropic B vitamins in the management of Peripheral Neuropathy
Dr. Pinzon Rizaldy Taslim (Indonesia)
Programme
Safe use of vitamin B6 in management of Peripheral Neuropathy
Prof Kongkiat Kulkantrakorn (Thailand)
Prof Kongkiat Kulkantrakorn (Thailand)
Wednesday, 9 April
17:30-18:30
Grand Hall 201
4th WHO Global Diabetes Compact anniversary: Achieving five diabetes targets in five years: Is integration to PHC/UHC the key?
Programme
Remarks from the
perspective of a person
living with diabetes
Heather Koga, Member, IDF Blue Circle
Voices
WHO Global Diabetes Compact: Four years of progress
Dr Guy Fones, Director a.i., Department of
Noncommunicable Diseases,
Rehabilitation and Disability, WHO HQ
IDF remarks:
Achieving global diabetes
targets in five years (2030)
Prof Peter Schwarz, President, IDF
Programme
Panel Discussion on
Integrating Diabetes into
PHC/UHC
Panellists: Heather Koga, Dr Krisada Hanbunjerd, Dr Nikhil Tandon, Chair, Leif Fenger Jensen
Moderator: Dr Guy Fones
Q&A with the
audience
Closing remarks
Wednesday, 9 April
12:30-13:30
Grand Hall 202
Revolutionizing Diabetes Care with CGM: Innovation for Accessibility and Ease
Programme
Opening and Introduction
CGM as the Standard of Care
Prof. Satish Garg (USA)
CGM to Elevate Quality of Life
Prof. Alice Cheng (Canada)
CGM Access for All?
Dr. Viswanathan Mohan (India)
Q&A and Closing
All faculty
Wednesday, 9 April
12:30-13:30
Nile 1
Seeing Beyond the Numbers in Type 2 Diabetes: Empowering Patients for Optimal Weight and Glycaemic Management
Programme
Chair: Prof. Melanie Davies (UK)
Introduction: Challenges in Weight and Glycaemic Management
Following the Patients’ Journeys
- Integrating Weight and Glycaemic Management: Overcoming Clinical Inertia and Barriers to Effective Treatment
- Utilising Shared Decision-Making in Treatment Choices
- Incorporating Multidisciplinary Team Approaches
Symposium Summary and Q&A
Wednesday, 9 April
17:30-19:00
Nile 2
Unlocking Innovation in Diabetes & Metabolic Health
Programme
Welcome and introduction
Dr Mangesh Tiwaskar
President Address
Dr Jyotirmoy Pal
Type 2 diabetes phenotypes and clusters – Evolving science
Dr Shashank Joshi
How technology is “tech-ing” on type 1 diabetes: case-based perspectives
Dr Banshi Saboo
Programme
Role of Adiposity in Diabetes Management
Dr Sanjay Agarwal
Panel Discussion
Dr Agam Vora and Panelists
Prevalence and Disease Burden of Diabetic Peripheral Neuropathy in India-
Epidemiological Insights
Dr V. Mohan
Thank you
Dr Agam Vora
Wednesday, 9 April
12:30-13:30
Silk 1
Metformin and Insulin Resistance: Bridging Science and Clinical Practice
Programme
Welcome and introduction
Chaicharn Deerochanawong (Thailand)
Metformin in early and impending diabetes
Nemencio Nicodemus (the Philippines)
Metformin in PCOS
Anju Joham (Australia)
Metformin during pregnancy
Dittakarn Boriboonhirunsarn (Thailand)
Wednesday, 9 April
12:30-13:30
Silk 2
Early Combinational Therapy of DPP-4i Plus SGLT2i: Patient Profile, Approaches, Strategies, Guidelines, and Pitfalls
Programme
Chairperson: Dr. Apichati Vichayanrat
Welcome and Opening Remarks
Keynote Lecture: “Early Combinational Therapy of DPP-4i Plus SGLT2i”
Prof. Peter Schwarz
_Rationale for early combination therapy.
_Patient profiles suitable for DPP-4i and SGLT2i combination.
_Clinical approaches and strategies.
_Current guidelines and evidence-based recommendations.
_Common pitfalls and how to avoid them.
Programme
Questions and Answers
Moderator: Dr. Apichati Vichayanrat
Speaker: Prof. Peter Schwarz
Closing Remarks and Summary
Dr. Apichati Vichayanrat
Thursday, 10 April
12:30-13:30
Silk 2
Life for a Child Program update, including analogue insulin studies with partners